nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP1A2—Pentoxifylline—systemic scleroderma	0.152	0.389	CbGbCtD
Betaxolol—CYP1A2—Leflunomide—systemic scleroderma	0.145	0.371	CbGbCtD
Betaxolol—CYP2D6—Captopril—systemic scleroderma	0.0939	0.24	CbGbCtD
Betaxolol—Body temperature increased—Azathioprine—systemic scleroderma	0.000353	0.000579	CcSEcCtD
Betaxolol—Skin disorder—Lisinopril—systemic scleroderma	0.000352	0.000578	CcSEcCtD
Betaxolol—Malaise—Mycophenolate mofetil—systemic scleroderma	0.00035	0.000576	CcSEcCtD
Betaxolol—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00035	0.000575	CcSEcCtD
Betaxolol—Diarrhoea—Captopril—systemic scleroderma	0.00035	0.000575	CcSEcCtD
Betaxolol—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000349	0.000574	CcSEcCtD
Betaxolol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000349	0.000574	CcSEcCtD
Betaxolol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000348	0.000573	CcSEcCtD
Betaxolol—Erectile dysfunction—Prednisone—systemic scleroderma	0.000348	0.000572	CcSEcCtD
Betaxolol—Feeling abnormal—Leflunomide—systemic scleroderma	0.000347	0.00057	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000347	0.00057	CcSEcCtD
Betaxolol—Fatigue—Mycophenolic acid—systemic scleroderma	0.000346	0.000569	CcSEcCtD
Betaxolol—Mood swings—Methotrexate—systemic scleroderma	0.000346	0.000569	CcSEcCtD
Betaxolol—Nausea—Mometasone—systemic scleroderma	0.000346	0.000568	CcSEcCtD
Betaxolol—Anorexia—Lisinopril—systemic scleroderma	0.000345	0.000567	CcSEcCtD
Betaxolol—Weight increased—Prednisone—systemic scleroderma	0.000344	0.000565	CcSEcCtD
Betaxolol—Ataxia—Methotrexate—systemic scleroderma	0.000344	0.000565	CcSEcCtD
Betaxolol—Pain—Mycophenolic acid—systemic scleroderma	0.000344	0.000565	CcSEcCtD
Betaxolol—Constipation—Mycophenolic acid—systemic scleroderma	0.000344	0.000565	CcSEcCtD
Betaxolol—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000343	0.000564	CcSEcCtD
Betaxolol—Weight decreased—Prednisone—systemic scleroderma	0.000342	0.000562	CcSEcCtD
Betaxolol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000341	0.000561	CcSEcCtD
Betaxolol—Hyperglycaemia—Prednisone—systemic scleroderma	0.000341	0.00056	CcSEcCtD
Betaxolol—Cough—Mycophenolate mofetil—systemic scleroderma	0.000339	0.000557	CcSEcCtD
Betaxolol—Hypotension—Lisinopril—systemic scleroderma	0.000338	0.000556	CcSEcCtD
Betaxolol—Dizziness—Captopril—systemic scleroderma	0.000338	0.000555	CcSEcCtD
Betaxolol—Depression—Prednisone—systemic scleroderma	0.000336	0.000552	CcSEcCtD
Betaxolol—Urticaria—Leflunomide—systemic scleroderma	0.000335	0.00055	CcSEcCtD
Betaxolol—Body temperature increased—Leflunomide—systemic scleroderma	0.000333	0.000547	CcSEcCtD
Betaxolol—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000332	0.000546	CcSEcCtD
Betaxolol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000331	0.000544	CcSEcCtD
Betaxolol—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000544	CcSEcCtD
Betaxolol—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000544	CcSEcCtD
Betaxolol—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000331	0.000544	CcSEcCtD
Betaxolol—Myocardial infarction—Prednisone—systemic scleroderma	0.00033	0.000543	CcSEcCtD
Betaxolol—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00033	0.000543	CcSEcCtD
Betaxolol—Breast disorder—Methotrexate—systemic scleroderma	0.00033	0.000543	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00033	0.000542	CcSEcCtD
Betaxolol—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00033	0.000542	CcSEcCtD
Betaxolol—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000329	0.000541	CcSEcCtD
Betaxolol—Hypersensitivity—Azathioprine—systemic scleroderma	0.000329	0.00054	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000329	0.00054	CcSEcCtD
Betaxolol—Insomnia—Lisinopril—systemic scleroderma	0.000327	0.000538	CcSEcCtD
Betaxolol—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000327	0.000537	CcSEcCtD
Betaxolol—Paraesthesia—Lisinopril—systemic scleroderma	0.000325	0.000534	CcSEcCtD
Betaxolol—Vomiting—Captopril—systemic scleroderma	0.000325	0.000534	CcSEcCtD
Betaxolol—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000324	0.000532	CcSEcCtD
Betaxolol—Dyspnoea—Lisinopril—systemic scleroderma	0.000323	0.00053	CcSEcCtD
Betaxolol—Rash—Captopril—systemic scleroderma	0.000322	0.00053	CcSEcCtD
Betaxolol—Dermatitis—Captopril—systemic scleroderma	0.000322	0.000529	CcSEcCtD
Betaxolol—Headache—Captopril—systemic scleroderma	0.00032	0.000526	CcSEcCtD
Betaxolol—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00032	0.000525	CcSEcCtD
Betaxolol—Dyspepsia—Lisinopril—systemic scleroderma	0.000319	0.000524	CcSEcCtD
Betaxolol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000318	0.000522	CcSEcCtD
Betaxolol—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000317	0.000521	CcSEcCtD
Betaxolol—Asthma—Methotrexate—systemic scleroderma	0.000316	0.000519	CcSEcCtD
Betaxolol—Infection—Mycophenolate mofetil—systemic scleroderma	0.000315	0.000518	CcSEcCtD
Betaxolol—Decreased appetite—Lisinopril—systemic scleroderma	0.000315	0.000517	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000312	0.000513	CcSEcCtD
Betaxolol—Fatigue—Lisinopril—systemic scleroderma	0.000312	0.000513	CcSEcCtD
Betaxolol—Shock—Mycophenolate mofetil—systemic scleroderma	0.000312	0.000513	CcSEcCtD
Betaxolol—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000311	0.000511	CcSEcCtD
Betaxolol—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00031	0.00051	CcSEcCtD
Betaxolol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00031	0.00051	CcSEcCtD
Betaxolol—Pain—Lisinopril—systemic scleroderma	0.000309	0.000509	CcSEcCtD
Betaxolol—Constipation—Lisinopril—systemic scleroderma	0.000309	0.000509	CcSEcCtD
Betaxolol—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000309	0.000509	CcSEcCtD
Betaxolol—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000308	0.000506	CcSEcCtD
Betaxolol—Bradycardia—Prednisone—systemic scleroderma	0.000308	0.000506	CcSEcCtD
Betaxolol—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000307	0.000504	CcSEcCtD
Betaxolol—Diarrhoea—Azathioprine—systemic scleroderma	0.000305	0.000502	CcSEcCtD
Betaxolol—Nausea—Captopril—systemic scleroderma	0.000304	0.000499	CcSEcCtD
Betaxolol—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000302	0.000497	CcSEcCtD
Betaxolol—Asthenia—Leflunomide—systemic scleroderma	0.000302	0.000497	CcSEcCtD
Betaxolol—Hallucination—Prednisone—systemic scleroderma	0.000301	0.000495	CcSEcCtD
Betaxolol—Feeling abnormal—Lisinopril—systemic scleroderma	0.000298	0.00049	CcSEcCtD
Betaxolol—Pruritus—Leflunomide—systemic scleroderma	0.000298	0.00049	CcSEcCtD
Betaxolol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000296	0.000487	CcSEcCtD
Betaxolol—Dysuria—Methotrexate—systemic scleroderma	0.000295	0.000485	CcSEcCtD
Betaxolol—Dizziness—Azathioprine—systemic scleroderma	0.000295	0.000485	CcSEcCtD
Betaxolol—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000294	0.000482	CcSEcCtD
Betaxolol—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000291	0.000478	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000289	0.000475	CcSEcCtD
Betaxolol—Asthenia—Mycophenolic acid—systemic scleroderma	0.000288	0.000474	CcSEcCtD
Betaxolol—Diarrhoea—Leflunomide—systemic scleroderma	0.000288	0.000474	CcSEcCtD
Betaxolol—Urticaria—Lisinopril—systemic scleroderma	0.000288	0.000472	CcSEcCtD
Betaxolol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000287	0.000471	CcSEcCtD
Betaxolol—Body temperature increased—Lisinopril—systemic scleroderma	0.000286	0.00047	CcSEcCtD
Betaxolol—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000285	0.000468	CcSEcCtD
Betaxolol—Pruritus—Mycophenolic acid—systemic scleroderma	0.000284	0.000467	CcSEcCtD
Betaxolol—Vomiting—Azathioprine—systemic scleroderma	0.000284	0.000466	CcSEcCtD
Betaxolol—Pneumonia—Methotrexate—systemic scleroderma	0.000283	0.000466	CcSEcCtD
Betaxolol—Eye disorder—Prednisone—systemic scleroderma	0.000283	0.000465	CcSEcCtD
Betaxolol—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000283	0.000465	CcSEcCtD
Betaxolol—Infestation NOS—Methotrexate—systemic scleroderma	0.000282	0.000463	CcSEcCtD
Betaxolol—Infestation—Methotrexate—systemic scleroderma	0.000282	0.000463	CcSEcCtD
Betaxolol—Rash—Azathioprine—systemic scleroderma	0.000281	0.000462	CcSEcCtD
Betaxolol—Dermatitis—Azathioprine—systemic scleroderma	0.000281	0.000462	CcSEcCtD
Betaxolol—Depression—Methotrexate—systemic scleroderma	0.000281	0.000462	CcSEcCtD
Betaxolol—Flushing—Prednisone—systemic scleroderma	0.000281	0.000461	CcSEcCtD
Betaxolol—Headache—Azathioprine—systemic scleroderma	0.000279	0.000459	CcSEcCtD
Betaxolol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000279	0.000459	CcSEcCtD
Betaxolol—Dizziness—Leflunomide—systemic scleroderma	0.000279	0.000458	CcSEcCtD
Betaxolol—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000276	0.000453	CcSEcCtD
Betaxolol—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000275	0.000452	CcSEcCtD
Betaxolol—Stomatitis—Methotrexate—systemic scleroderma	0.000275	0.000451	CcSEcCtD
Betaxolol—Angiopathy—Prednisone—systemic scleroderma	0.000274	0.000451	CcSEcCtD
Betaxolol—Conjunctivitis—Methotrexate—systemic scleroderma	0.000274	0.00045	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000274	0.00045	CcSEcCtD
Betaxolol—Immune system disorder—Prednisone—systemic scleroderma	0.000273	0.000449	CcSEcCtD
Betaxolol—Pain—Mycophenolate mofetil—systemic scleroderma	0.000271	0.000446	CcSEcCtD
Betaxolol—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000271	0.000446	CcSEcCtD
Betaxolol—Arrhythmia—Prednisone—systemic scleroderma	0.00027	0.000444	CcSEcCtD
Betaxolol—Sweating—Methotrexate—systemic scleroderma	0.00027	0.000444	CcSEcCtD
Betaxolol—Vomiting—Leflunomide—systemic scleroderma	0.000268	0.00044	CcSEcCtD
Betaxolol—Alopecia—Prednisone—systemic scleroderma	0.000267	0.000439	CcSEcCtD
Betaxolol—Hypersensitivity—Lisinopril—systemic scleroderma	0.000267	0.000438	CcSEcCtD
Betaxolol—Dizziness—Mycophenolic acid—systemic scleroderma	0.000266	0.000437	CcSEcCtD
Betaxolol—Epistaxis—Methotrexate—systemic scleroderma	0.000266	0.000437	CcSEcCtD
Betaxolol—Rash—Leflunomide—systemic scleroderma	0.000266	0.000436	CcSEcCtD
Betaxolol—Dermatitis—Leflunomide—systemic scleroderma	0.000265	0.000436	CcSEcCtD
Betaxolol—Mental disorder—Prednisone—systemic scleroderma	0.000265	0.000436	CcSEcCtD
Betaxolol—Nausea—Azathioprine—systemic scleroderma	0.000265	0.000435	CcSEcCtD
Betaxolol—Headache—Leflunomide—systemic scleroderma	0.000264	0.000434	CcSEcCtD
Betaxolol—Malnutrition—Prednisone—systemic scleroderma	0.000263	0.000433	CcSEcCtD
Betaxolol—Erythema—Prednisone—systemic scleroderma	0.000263	0.000433	CcSEcCtD
Betaxolol—Agranulocytosis—Methotrexate—systemic scleroderma	0.000263	0.000432	CcSEcCtD
Betaxolol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000261	0.000429	CcSEcCtD
Betaxolol—Asthenia—Lisinopril—systemic scleroderma	0.00026	0.000427	CcSEcCtD
Betaxolol—Pruritus—Lisinopril—systemic scleroderma	0.000256	0.000421	CcSEcCtD
Betaxolol—Vomiting—Mycophenolic acid—systemic scleroderma	0.000255	0.00042	CcSEcCtD
Betaxolol—Rash—Mycophenolic acid—systemic scleroderma	0.000253	0.000416	CcSEcCtD
Betaxolol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000253	0.000416	CcSEcCtD
Betaxolol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000252	0.000414	CcSEcCtD
Betaxolol—Headache—Mycophenolic acid—systemic scleroderma	0.000252	0.000414	CcSEcCtD
Betaxolol—Pharyngitis—Methotrexate—systemic scleroderma	0.000251	0.000412	CcSEcCtD
Betaxolol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000251	0.000412	CcSEcCtD
Betaxolol—Nausea—Leflunomide—systemic scleroderma	0.00025	0.000411	CcSEcCtD
Betaxolol—Vision blurred—Prednisone—systemic scleroderma	0.000248	0.000408	CcSEcCtD
Betaxolol—Diarrhoea—Lisinopril—systemic scleroderma	0.000248	0.000407	CcSEcCtD
Betaxolol—Ill-defined disorder—Prednisone—systemic scleroderma	0.000244	0.000402	CcSEcCtD
Betaxolol—Visual impairment—Methotrexate—systemic scleroderma	0.000244	0.0004	CcSEcCtD
Betaxolol—Anaemia—Prednisone—systemic scleroderma	0.000243	0.0004	CcSEcCtD
Betaxolol—Dizziness—Lisinopril—systemic scleroderma	0.000239	0.000393	CcSEcCtD
Betaxolol—Nausea—Mycophenolic acid—systemic scleroderma	0.000239	0.000392	CcSEcCtD
Betaxolol—Malaise—Prednisone—systemic scleroderma	0.000238	0.00039	CcSEcCtD
Betaxolol—Vertigo—Prednisone—systemic scleroderma	0.000237	0.000389	CcSEcCtD
Betaxolol—Eye disorder—Methotrexate—systemic scleroderma	0.000236	0.000388	CcSEcCtD
Betaxolol—Syncope—Prednisone—systemic scleroderma	0.000236	0.000388	CcSEcCtD
Betaxolol—Tinnitus—Methotrexate—systemic scleroderma	0.000236	0.000387	CcSEcCtD
Betaxolol—Cardiac disorder—Methotrexate—systemic scleroderma	0.000235	0.000386	CcSEcCtD
Betaxolol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000234	0.000384	CcSEcCtD
Betaxolol—Loss of consciousness—Prednisone—systemic scleroderma	0.000231	0.00038	CcSEcCtD
Betaxolol—Vomiting—Lisinopril—systemic scleroderma	0.00023	0.000378	CcSEcCtD
Betaxolol—Angiopathy—Methotrexate—systemic scleroderma	0.000229	0.000377	CcSEcCtD
Betaxolol—Immune system disorder—Methotrexate—systemic scleroderma	0.000228	0.000375	CcSEcCtD
Betaxolol—Rash—Lisinopril—systemic scleroderma	0.000228	0.000375	CcSEcCtD
Betaxolol—Dermatitis—Lisinopril—systemic scleroderma	0.000228	0.000375	CcSEcCtD
Betaxolol—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000228	0.000374	CcSEcCtD
Betaxolol—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000374	CcSEcCtD
Betaxolol—Chills—Methotrexate—systemic scleroderma	0.000227	0.000373	CcSEcCtD
Betaxolol—Headache—Lisinopril—systemic scleroderma	0.000227	0.000373	CcSEcCtD
Betaxolol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000224	0.000369	CcSEcCtD
Betaxolol—Arthralgia—Prednisone—systemic scleroderma	0.000224	0.000368	CcSEcCtD
Betaxolol—Myalgia—Prednisone—systemic scleroderma	0.000224	0.000368	CcSEcCtD
Betaxolol—Anxiety—Prednisone—systemic scleroderma	0.000223	0.000367	CcSEcCtD
Betaxolol—Alopecia—Methotrexate—systemic scleroderma	0.000223	0.000367	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000223	0.000366	CcSEcCtD
Betaxolol—Discomfort—Prednisone—systemic scleroderma	0.000222	0.000364	CcSEcCtD
Betaxolol—Mental disorder—Methotrexate—systemic scleroderma	0.000222	0.000364	CcSEcCtD
Betaxolol—Malnutrition—Methotrexate—systemic scleroderma	0.00022	0.000362	CcSEcCtD
Betaxolol—Erythema—Methotrexate—systemic scleroderma	0.00022	0.000362	CcSEcCtD
Betaxolol—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000217	0.000357	CcSEcCtD
Betaxolol—Dysgeusia—Methotrexate—systemic scleroderma	0.000216	0.000354	CcSEcCtD
Betaxolol—Nausea—Lisinopril—systemic scleroderma	0.000215	0.000353	CcSEcCtD
Betaxolol—Oedema—Prednisone—systemic scleroderma	0.000215	0.000353	CcSEcCtD
Betaxolol—Infection—Prednisone—systemic scleroderma	0.000214	0.000351	CcSEcCtD
Betaxolol—Shock—Prednisone—systemic scleroderma	0.000211	0.000348	CcSEcCtD
Betaxolol—Nervous system disorder—Prednisone—systemic scleroderma	0.000211	0.000346	CcSEcCtD
Betaxolol—Tachycardia—Prednisone—systemic scleroderma	0.00021	0.000345	CcSEcCtD
Betaxolol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00021	0.000345	CcSEcCtD
Betaxolol—Skin disorder—Prednisone—systemic scleroderma	0.000209	0.000343	CcSEcCtD
Betaxolol—Hyperhidrosis—Prednisone—systemic scleroderma	0.000208	0.000341	CcSEcCtD
Betaxolol—Vision blurred—Methotrexate—systemic scleroderma	0.000207	0.000341	CcSEcCtD
Betaxolol—Anorexia—Prednisone—systemic scleroderma	0.000205	0.000337	CcSEcCtD
Betaxolol—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000204	0.000336	CcSEcCtD
Betaxolol—Anaemia—Methotrexate—systemic scleroderma	0.000203	0.000334	CcSEcCtD
Betaxolol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000202	0.000331	CcSEcCtD
Betaxolol—Rash—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000329	CcSEcCtD
Betaxolol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.0002	0.000328	CcSEcCtD
Betaxolol—Headache—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000326	CcSEcCtD
Betaxolol—Malaise—Methotrexate—systemic scleroderma	0.000198	0.000326	CcSEcCtD
Betaxolol—Vertigo—Methotrexate—systemic scleroderma	0.000198	0.000325	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000196	0.000322	CcSEcCtD
Betaxolol—Insomnia—Prednisone—systemic scleroderma	0.000194	0.000319	CcSEcCtD
Betaxolol—Paraesthesia—Prednisone—systemic scleroderma	0.000193	0.000317	CcSEcCtD
Betaxolol—Cough—Methotrexate—systemic scleroderma	0.000192	0.000316	CcSEcCtD
Betaxolol—Dyspepsia—Prednisone—systemic scleroderma	0.000189	0.000311	CcSEcCtD
Betaxolol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000188	0.00031	CcSEcCtD
Betaxolol—Chest pain—Methotrexate—systemic scleroderma	0.000187	0.000308	CcSEcCtD
Betaxolol—Myalgia—Methotrexate—systemic scleroderma	0.000187	0.000308	CcSEcCtD
Betaxolol—Arthralgia—Methotrexate—systemic scleroderma	0.000187	0.000308	CcSEcCtD
Betaxolol—Decreased appetite—Prednisone—systemic scleroderma	0.000187	0.000307	CcSEcCtD
Betaxolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000186	0.000306	CcSEcCtD
Betaxolol—Fatigue—Prednisone—systemic scleroderma	0.000185	0.000305	CcSEcCtD
Betaxolol—Discomfort—Methotrexate—systemic scleroderma	0.000185	0.000304	CcSEcCtD
Betaxolol—Constipation—Prednisone—systemic scleroderma	0.000184	0.000302	CcSEcCtD
Betaxolol—Confusional state—Methotrexate—systemic scleroderma	0.000181	0.000298	CcSEcCtD
Betaxolol—Infection—Methotrexate—systemic scleroderma	0.000178	0.000293	CcSEcCtD
Betaxolol—Feeling abnormal—Prednisone—systemic scleroderma	0.000177	0.000291	CcSEcCtD
Betaxolol—Nervous system disorder—Methotrexate—systemic scleroderma	0.000176	0.00029	CcSEcCtD
Betaxolol—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000176	0.000289	CcSEcCtD
Betaxolol—Skin disorder—Methotrexate—systemic scleroderma	0.000174	0.000287	CcSEcCtD
Betaxolol—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000174	0.000285	CcSEcCtD
Betaxolol—Anorexia—Methotrexate—systemic scleroderma	0.000171	0.000281	CcSEcCtD
Betaxolol—Urticaria—Prednisone—systemic scleroderma	0.000171	0.000281	CcSEcCtD
Betaxolol—Body temperature increased—Prednisone—systemic scleroderma	0.00017	0.000279	CcSEcCtD
Betaxolol—Hypotension—Methotrexate—systemic scleroderma	0.000168	0.000276	CcSEcCtD
Betaxolol—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000164	0.000269	CcSEcCtD
Betaxolol—Insomnia—Methotrexate—systemic scleroderma	0.000162	0.000267	CcSEcCtD
Betaxolol—Paraesthesia—Methotrexate—systemic scleroderma	0.000161	0.000265	CcSEcCtD
Betaxolol—Dyspnoea—Methotrexate—systemic scleroderma	0.00016	0.000263	CcSEcCtD
Betaxolol—Hypersensitivity—Prednisone—systemic scleroderma	0.000158	0.00026	CcSEcCtD
Betaxolol—Dyspepsia—Methotrexate—systemic scleroderma	0.000158	0.00026	CcSEcCtD
Betaxolol—Decreased appetite—Methotrexate—systemic scleroderma	0.000156	0.000257	CcSEcCtD
Betaxolol—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000155	0.000255	CcSEcCtD
Betaxolol—Fatigue—Methotrexate—systemic scleroderma	0.000155	0.000255	CcSEcCtD
Betaxolol—Asthenia—Prednisone—systemic scleroderma	0.000154	0.000253	CcSEcCtD
Betaxolol—Pain—Methotrexate—systemic scleroderma	0.000154	0.000252	CcSEcCtD
Betaxolol—Pruritus—Prednisone—systemic scleroderma	0.000152	0.00025	CcSEcCtD
Betaxolol—Feeling abnormal—Methotrexate—systemic scleroderma	0.000148	0.000243	CcSEcCtD
Betaxolol—Diarrhoea—Prednisone—systemic scleroderma	0.000147	0.000242	CcSEcCtD
Betaxolol—Urticaria—Methotrexate—systemic scleroderma	0.000143	0.000235	CcSEcCtD
Betaxolol—Dizziness—Prednisone—systemic scleroderma	0.000142	0.000234	CcSEcCtD
Betaxolol—Body temperature increased—Methotrexate—systemic scleroderma	0.000142	0.000233	CcSEcCtD
Betaxolol—Vomiting—Prednisone—systemic scleroderma	0.000137	0.000225	CcSEcCtD
Betaxolol—Rash—Prednisone—systemic scleroderma	0.000136	0.000223	CcSEcCtD
Betaxolol—Dermatitis—Prednisone—systemic scleroderma	0.000135	0.000223	CcSEcCtD
Betaxolol—Headache—Prednisone—systemic scleroderma	0.000135	0.000221	CcSEcCtD
Betaxolol—Hypersensitivity—Methotrexate—systemic scleroderma	0.000132	0.000218	CcSEcCtD
Betaxolol—Asthenia—Methotrexate—systemic scleroderma	0.000129	0.000212	CcSEcCtD
Betaxolol—Nausea—Prednisone—systemic scleroderma	0.000128	0.00021	CcSEcCtD
Betaxolol—Pruritus—Methotrexate—systemic scleroderma	0.000127	0.000209	CcSEcCtD
Betaxolol—Diarrhoea—Methotrexate—systemic scleroderma	0.000123	0.000202	CcSEcCtD
Betaxolol—Dizziness—Methotrexate—systemic scleroderma	0.000119	0.000195	CcSEcCtD
Betaxolol—Vomiting—Methotrexate—systemic scleroderma	0.000114	0.000188	CcSEcCtD
Betaxolol—Rash—Methotrexate—systemic scleroderma	0.000113	0.000186	CcSEcCtD
Betaxolol—Dermatitis—Methotrexate—systemic scleroderma	0.000113	0.000186	CcSEcCtD
Betaxolol—Headache—Methotrexate—systemic scleroderma	0.000113	0.000185	CcSEcCtD
Betaxolol—Nausea—Methotrexate—systemic scleroderma	0.000107	0.000175	CcSEcCtD
